130 related articles for article (PubMed ID: 6293188)
21. Antiviral effect of the extract of culture medium of Lentinus edodes mycelia on the replication of herpes simplex virus type 1.
Sarkar S; Koga J; Whitley RJ; Chatterjee S
Antiviral Res; 1993 Apr; 20(4):293-303. PubMed ID: 8387258
[TBL] [Abstract][Full Text] [Related]
22. Effect of 2-deoxy-D-glucose on herpesvirus-induced inhibition of cellular DNA synthesis.
Ludwig H; Rott R
J Virol; 1975 Aug; 16(2):217-21. PubMed ID: 168399
[TBL] [Abstract][Full Text] [Related]
23. Drugs in development for herpes simplex and varicella zoster virus.
Birkmann A; Zimmermann H
Clin Pharmacol Ther; 2017 Jul; 102(1):30-32. PubMed ID: 28160282
[TBL] [Abstract][Full Text] [Related]
24. Characterization of inhibitory action of concanamycins against herpes simplex virus.
Hayashi K; Kawauchi M; Nakai C; Sankawa U; Seto H; Hayashi T
Antivir Chem Chemother; 2001 Jan; 12(1):51-9. PubMed ID: 11437322
[TBL] [Abstract][Full Text] [Related]
25. Effect of 2-deoxy-D-glucose on the binding of preimmune and immune sera to herpes simplex virus-infected cells as measured by quantitative immunofluorescence.
Rajcáni J; Hulíková Z; Mucha V
Acta Virol; 1979 Sep; 23(5):403-11. PubMed ID: 42300
[TBL] [Abstract][Full Text] [Related]
26. Failure of 2-deoxy-D-glucose in the treatment of experimental cutaneous and genital infections due to herpes simplex virus.
Kern ER; Glasgow LA; Klein RJ; Friedman-Kien AE
J Infect Dis; 1982 Aug; 146(2):159-66. PubMed ID: 6286785
[TBL] [Abstract][Full Text] [Related]
27. The expression of the syn- gene of herpes simplex virus type 1. II. Requirements for macromolecular synthesis.
Keller JM
Virology; 1976 Jul; 72(2):402-9. PubMed ID: 181908
[No Abstract] [Full Text] [Related]
28. Effect of 2-deoxy-D-glucose on cell fusion induced by Newcastle disease and herpes simplex viruses.
Gallaher WR; Levitan DB; Blough HA
Virology; 1973 Sep; 55(1):193-201. PubMed ID: 4353953
[No Abstract] [Full Text] [Related]
29. [Resistance of herpes simplex virus to acyclovir: laboratory and clinical aspects].
Briazzhikova TS; Iurlova TI; Chizhov NP
Antibiot Khimioter; 1995; 40(11-12):29-33. PubMed ID: 8830636
[TBL] [Abstract][Full Text] [Related]
30. Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity.
Sarmiento M; Haffey M; Spear PG
J Virol; 1979 Mar; 29(3):1149-58. PubMed ID: 221669
[TBL] [Abstract][Full Text] [Related]
31. New anti-HSV therapeutics target the helicase-primase complex.
Crumpacker CS; Schaffer PA
Nat Med; 2002 Apr; 8(4):327-8. PubMed ID: 11927930
[No Abstract] [Full Text] [Related]
32. Interference of nucleoside diphosphate derivatives of 2-deoxy-D-glucose with the glycosylation of virus-specific glycoproteins in vivo.
Schmidt MF; Schwarz RT; Scholtissek C
Eur J Biochem; 1976 Nov; 70(1):55-62. PubMed ID: 1034557
[TBL] [Abstract][Full Text] [Related]
33. 5-(2-Chloroethyl)-2'-deoxyuridine: a potent and selective inhibitor of herpes viruses in vitro and in vivo.
Rosenwirth B; Griengl H; Wanek E; De Clercq E
Antiviral Res; 1985; Suppl 1():20-8. PubMed ID: 3002256
[No Abstract] [Full Text] [Related]
34. Effect of acyclovir on viral protein synthesis in cells infected with herpes simplex virus type 1.
Furman PA; McGuirt PV
Antimicrob Agents Chemother; 1983 Feb; 23(2):332-4. PubMed ID: 6301368
[TBL] [Abstract][Full Text] [Related]
35. Effects of 2-deoxy-D-glucose and 3 deazauridine individually and in combination on the replication of Japanese B encephalitis virus.
Woodman DR; Williams JC
Antimicrob Agents Chemother; 1977 Mar; 11(3):475-81. PubMed ID: 856001
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
Glorioso J; Szczesiul MS; Marlin SD; Levine M
Virology; 1983 Apr; 126(1):1-18. PubMed ID: 6189286
[TBL] [Abstract][Full Text] [Related]
37. [Course and treatment of herpervirus hominis infections. II. Therapy].
Luger A
Z Haut Geschlechtskr; 1971 Jul; 46(13):399-408. PubMed ID: 4331019
[No Abstract] [Full Text] [Related]
38. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
[TBL] [Abstract][Full Text] [Related]
39. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
de Clercq E
Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
[No Abstract] [Full Text] [Related]
40. [Inhibition of the multiplication of Tacaribe, Pichindé and Junín arenaviruses in the presence of glucosamine or 2-deoxy-D-glucose].
León ME; Coto CE
Rev Argent Microbiol; 1980; 12(2):59-61. PubMed ID: 7348316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
